Major thoracic surgery, particularly esophagectomy, carries a substantial risk of postoperative morbidity. Clinicians have long explored goal-directed fluid therapy (GDT) and hemodynamic optimization as strategies to improve outcomes.

A new randomized controlled trial published in Anesthesiology (2026) challenges this paradigm, showing that even highly individualized perioperative blood pressure and fluid strategies may not reduce complications.

Overview of the study

This prospective, single-blind randomized controlled trial evaluated whether extending individualized hemodynamic management beyond surgery improves outcomes.

Study design

• Population: 100 patients undergoing esophagectomy
• Intervention:
  • Extended goal-directed fluid therapy (eGDT)
  • Individualized mean arterial pressure (MAP) targets based on preoperative nighttime blood pressure
• Control: Standard hemodynamic care
• Duration of intervention: From anesthesia induction to the first postoperative morning

Primary outcome

• Comprehensive complication index (CCI) at 30 days

Key findings

No reduction in complications

• CCI score:
  • eGDT: 39.0 ± 20.0
  • Standard care: 39.2 ± 21.0
• No statistically or clinically significant difference

Increased intervention without benefit

Patients in the individualized group experienced:

• Higher fluid administration
• Increased norepinephrine use
• Slightly higher mean arterial pressure

Despite these changes:

• No improvement in postoperative morbidity
• No difference in hospital or ICU length of stay 

Complication burden remained high

• 98% of patients in the intervention group had at least one complication
• 96% in standard care
• Over 460 complications recorded at 30 days

What is goal-directed fluid therapy?

Goal-directed fluid therapy (GDT) aims to optimize:

• Cardiac output
• Tissue perfusion
• Oxygen delivery

Traditional approach

• Uses dynamic parameters such as:
  • Stroke volume variation (SVV)
  • Cardiac output monitoring
• Often applies fixed MAP thresholds (e.g., ≥65 mmHg)

What makes this study different?

This trial introduced two key innovations:

1. Individualized blood pressure targets

• MAP targets derived from each patient’s baseline nighttime blood pressure
• Range typically between 65–85 mmHg

2. Extended therapy into postoperative period

• Continued hemodynamic optimization until the morning after surgery
• Addresses:
  • Fluid shifts
  • ICU hemodynamic instability 

Why didn’t individualized therapy improve outcomes?

1. Minimal hemodynamic separation

• Actual MAP difference between groups: ~3 mmHg
• Clinically insignificant despite different targets

2. Macro vs microcirculation mismatch

Optimizing global parameters (MAP, cardiac output) does not guarantee:

• Adequate microvascular perfusion
• Tissue oxygenation

3. Improved standard care

Modern perioperative care already includes:

• Careful fluid management
• Real-time hemodynamic assessment
• Reduced variability in practice

This may reduce the added benefit of protocolized GDT.

4. Physiological complexity after surgery

Postoperative changes include:

• Increased oxygen demand after extubation
• Altered cardiac loading conditions
• Dynamic fluid redistribution

These factors may limit the effectiveness of fixed protocols.

Clinical implications

What this means for anesthesiologists

• Routine use of extended, individualized GDT may not be justified
• Focus should shift toward:
  • Clinical judgment
  • Dynamic reassessment
  • Avoiding fluid overload

Important considerations

• Overuse of vasopressors and fluids may:
  • Increase complications
  • Add unnecessary complexity

Conclusion

This landmark trial provides important clarity:

• Individualized blood pressure and fluid therapy did not improve outcomes after esophagectomy
• Increased intervention intensity did not translate into clinical benefit
• The role of goal-directed therapy is being re-evaluated in modern perioperative care

The future likely lies not in more aggressive hemodynamic manipulation, but in better understanding tissue-level physiology and individualized patient response.

Reference: Hovgaard HL et al. Individualized Perioperative Blood Pressure and Fluid Therapy in Esophagectomy: A Prospective, Single-blind Randomized Controlled Trial. Anesthesiology. 2026;144:823-836.

Explore more about the management of esophagectomy patients in NYSORA’s Anesthesiology Manual. And for a digital learning experience, check out the Anesthesiology Module on NYSORA360!